Graph Therapeutics is advancing internal drug discovery programs across multiple inflammatory and immune-mediated disease indications. The company's platform combines live patient cell models with advanced machine learning to decode complex immune dysfunction and identify disease mechanisms, drug targets, and biomarkers for immune-mediated diseases.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| $5 M | Jun, 2026 | unspecified |
Frequently Asked Questions
Where is Graph Therapeutics located?
Graph Therapeutics is located in Vienna, Austria.
What industries does Graph Therapeutics operate in?
Graph Therapeutics operates in the following industries: biotechnology, drug discovery, immunology, artificial intelligence.
Who are the investors in Graph Therapeutics?
The investors in Graph Therapeutics are: Daphni, SquareOne, Merantix Capital, NAVEC Investment Management, Austrian Research Promotion Agency (FFG), Austria Wirtschaftsservice (AWS).